{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:50:14Z","timestamp":1791579014996,"version":"4.3.4"},"reference-count":139,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["252300423769"],"award-info":[{"award-number":["252300423769"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbcan.2026.189727","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:42:47Z","timestamp":1790811767000},"page":"189727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lysine specific demethylase 5B promises to be a new focus of cancer drug-resistance: combination therapy"],"prefix":"10.1016","volume":"1881","author":[{"given":"Yaquan","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiangui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoguo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbcan.2026.189727_bb0005","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"1\u20132","key":"10.1016\/j.bbcan.2026.189727_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.drup.2012.01.008","article-title":"Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance","volume":"15","author":"Wilting","year":"2012","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bbcan.2026.189727_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128654","article-title":"Novel indazole skeleton derivatives containing 1,2,3-triazole as potential anti-prostate cancer drugs","volume":"64","author":"Cao","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189727_bb0020","doi-asserted-by":"crossref","first-page":"590","DOI":"10.6023\/cjoc202107049","article-title":"Synthesis and antitumor activity of novel 5- and 6-substituted indazole derivatives","volume":"42","author":"Wu","year":"2022","journal-title":"Chin. J. Org. Chem."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189727_bb0025","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: an overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189727_bb0030","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/annonc\/mdy102","article-title":"Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions","volume":"29","author":"Haddad","year":"2018","journal-title":"Ann. Oncol."},{"issue":"24","key":"10.1016\/j.bbcan.2026.189727_bb0035","doi-asserted-by":"crossref","first-page":"37297","DOI":"10.18632\/oncotarget.8934","article-title":"Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients","volume":"7","author":"Fayette","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189727_bb0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3892\/mco.2017.1281","article-title":"Efficacy and toxicity of docetaxel combination chemotherapy for advanced squamous cell cancer of the head and neck","volume":"7","author":"Albers","year":"2017","journal-title":"Mol. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189727_bb0045","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.tranon.2019.01.002","article-title":"Cisplatin and fluorouracil induction chemotherapy with or without docetaxel in locoregionally advanced nasopharyngeal carcinoma","volume":"12","author":"Jin","year":"2019","journal-title":"Transl. Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189727_bb0050","article-title":"Docetaxel in the treatment of squamous cell carcinoma of the head and neck","volume":"4","author":"Rapidis","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"issue":"15","key":"10.1016\/j.bbcan.2026.189727_bb0055","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1021\/jm300207s","article-title":"Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein","volume":"55","author":"Debnath","year":"2012","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189727_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23587","article-title":"Lysine demethylase 5B (KDM5B): a key regulator of cancer drug resistance","volume":"38","author":"Cao","year":"2023","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bbcan.2026.189727_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100889","article-title":"Precision medicine: ray of hope in overcoming cancer multidrug resistance","volume":"65","author":"Musyuni","year":"2022","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bbcan.2026.189727_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2017.00113","article-title":"Third-generation tyrosine kinase inhibitors targeting epidermal growth factor receptor mutations in non-small cell lung cancer","volume":"7","author":"Barnes","year":"2017","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189727_bb0075","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1158\/0008-5472.CAN-07-5659","article-title":"PIK3CA mutation\/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor Cetuximab","volume":"68","author":"Jhawer","year":"2008","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189727_bb0080","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1097\/JTO.0000000000000688","article-title":"Mechanisms of acquired resistance to AZD9291","volume":"10","author":"Kim","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"24","key":"10.1016\/j.bbcan.2026.189727_bb0085","doi-asserted-by":"crossref","first-page":"6751","DOI":"10.1158\/1078-0432.CCR-13-0423","article-title":"Increased TGF-\u03b1 as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR\u2013MET interaction and activation of MET signaling in colon cancer cells","volume":"19","author":"Troiani","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189727_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13665","article-title":"Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer","volume":"7","author":"Van Emburgh","year":"2016","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189727_bb0095","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ccell.2016.08.001","article-title":"Feedback activation of leukemia inhibitory factor receptor limits response to histone deacetylase inhibitors in breast cancer","volume":"30","author":"Zeng","year":"2016","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189727_bb0100","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1021\/acsanm.2c00655","article-title":"Tetracycline encapsulated in au nanoparticle-decorated ZnO Nanohybrids for enhanced antibacterial activity","volume":"5","author":"Ahmed","year":"2022","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.bbcan.2026.189727_bb0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jconrel.2021.10.028","article-title":"RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy","volume":"340","author":"Sheikh","year":"2021","journal-title":"Journal of Controlled Release: Official Journal of the Controlled Release Society"},{"issue":"7194","key":"10.1016\/j.bbcan.2026.189727_bb0110","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature06965","article-title":"Transcriptome-wide noise controls lineage choice in mammalian progenitor cells","volume":"453","author":"Chang","year":"2008","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189727_bb0115","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.drup.2011.08.001","article-title":"Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategies","volume":"14","author":"Crea","year":"2011","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bbcan.2026.189727_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100821","article-title":"Epigenetic enzyme mutations as mediators of anti-cancer drug resistance","volume":"61","author":"Chen","year":"2022","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bbcan.2026.189727_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115250","article-title":"Discovery of a novel 1H-pyrazole- [3,4-b] pyridine-based lysine demethylase 5B inhibitor with potential anti-prostate cancer activity that perturbs the phosphoinositide 3-kinase\/AKT pathway","volume":"251","author":"Cao","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189727_bb0130","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1158\/0008-5472.CAN-17-1453","article-title":"A KDM5 inhibitor increases global H3K4 Trimethylation occupancy and enhances the biological efficacy of 5-Aza-2\u2032-deoxycytidine","volume":"78","author":"Leadem","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189727_bb0135","first-page":"57","article-title":"Research progress of lysine specific Demethylase 1 in carcinoma","volume":"36","author":"Jie","year":"2015","journal-title":"Medicine & Philosophy(B)"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189727_bb0140","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.drudis.2014.12.013","article-title":"Structural definitions of Jumonji family demethylase selectivity","volume":"20","author":"Pilka","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189727_bb0145","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.cell.2007.02.003","article-title":"RBP2 belongs to a family of demethylases, specific for tri-and Dimethylated lysine 4 on histone 3","volume":"128","author":"Christensen","year":"2007","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189727_bb0150","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2007.03.001","article-title":"PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation","volume":"25","author":"Yamane","year":"2007","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189727_bb0155","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.cell.2007.02.017","article-title":"The X-linked mental retardation gene SMCX\/JARID1C defines a family of histone H3 lysine 4 demethylases","volume":"128","author":"Iwase","year":"2007","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189727_bb0160","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s13238-014-0078-4","article-title":"The PHD1 finger of KDM5B recognizes unmodified H3K4 during the demethylation of histone H3K4me2\/3 by KDM5B","volume":"5","author":"Zhang","year":"2014","journal-title":"Protein Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189727_bb0165","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1074\/jbc.M115.698449","article-title":"Characterization of a linked Jumonji domain of the KDM5\/JARID1 family of histone H3 lysine 4 demethylases","volume":"291","author":"Horton","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2026.189727_bb0170","first-page":"66","article-title":"DNA-binding properties of ARID family proteins","volume":"1","author":"Antonia","year":"2005","journal-title":"Nucleic Acids Res."},{"issue":"49","key":"10.1016\/j.bbcan.2026.189727_bb0175","doi-asserted-by":"crossref","first-page":"19226","DOI":"10.1073\/pnas.0700735104","article-title":"JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer","volume":"104","author":"Xiang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189727_bb0180","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nchembio.2087","article-title":"Structural analysis of human KDM5B guides histone demethylase inhibitor development","volume":"12","author":"Johansson","year":"2026","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/j.bbcan.2026.189727_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.tibs.2011.03.005","article-title":"The PHD finger: a versatile epigenome reader","author":"Sanchez","year":"2011","journal-title":"Trends Biochem. Sci."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189727_bb0190","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/156802662004200304124340","article-title":"Targeting KDM5 demethylases: inhibition and degradation","volume":"20","author":"Fu","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189727_bb0195","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-019-0811-9","article-title":"LSD1\/KDM1A inhibitors in clinical trials: advances and prospects","volume":"12","author":"Fang","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"49","key":"10.1016\/j.bbcan.2026.189727_bb0200","doi-asserted-by":"crossref","first-page":"35425","DOI":"10.1074\/jbc.R700027200","article-title":"Structure and mechanism of lysine-specific demethylase enzymes","volume":"282","author":"Anand","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189727_bb0205","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/1947601911417976","article-title":"Targeting histone demethylases: a new avenue for the fight against cancer","volume":"2","author":"Dante","year":"2011","journal-title":"Genes Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189727_bb0210","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10549-011-1480-8","article-title":"Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells","volume":"131","author":"Huang","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189727_bb0215","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/1947601911417976","article-title":"Targeting histone demethylases: a new avenue for the fight against Cancer","volume":"2","author":"Rotili","year":"2011","journal-title":"Genes Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189727_bb0220","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2217\/epi.14.14","article-title":"The KDM5 family of histone demethylases as targets in oncology drug discovery","volume":"6","author":"Rasmussen","year":"2014","journal-title":"Epigenomics"},{"issue":"15","key":"10.1016\/j.bbcan.2026.189727_bb0225","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189727_bb0230","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.dnarep.2017.10.007","article-title":"XRCC1-mediated repair of strand breaks independent of PNKP binding","volume":"60","author":"Horton","year":"2017","journal-title":"DNA Repair"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189727_bb0235","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1002\/jcb.27073","article-title":"Effect of 5-fluorouracil on excision repair cross-complementing 1 expression and consequent cytotoxicity regulation in human gastric cancer cells","volume":"119","author":"Liu","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbcan.2026.189727_bb0240","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fmolb.2020.00070","article-title":"XRCC1 is a promising predictive biomarker and facilitates chemo-resistance in gallbladder cancer","volume":"7","author":"Wu","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189727_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.27","article-title":"TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer","volume":"5","author":"Xu","year":"2014","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189727_bb0250","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.7150\/ijbs.25881","article-title":"KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance","volume":"14","author":"Xu","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189727_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/genes10080612","article-title":"Identification of key genes and pathways in pancreatic cancer gene expression profile by integrative analysis","volume":"10","author":"Lu","year":"2019","journal-title":"Genes (Basel)"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189727_bb0260","doi-asserted-by":"crossref","first-page":"8054","DOI":"10.3390\/curroncol31120594","article-title":"Targeting TOP2A in ovarian cancer: biological and clinical implications","volume":"31","author":"Borella","year":"2024","journal-title":"Curr. Oncol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189727_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/genes10110859","article-title":"Cell cycle-dependent control and roles of DNA topoisomerase II","volume":"10","author":"Lee","year":"2019","journal-title":"Genes (Basel)"},{"issue":"19","key":"10.1016\/j.bbcan.2026.189727_bb0270","doi-asserted-by":"crossref","first-page":"7177","DOI":"10.1073\/pnas.85.19.7177","article-title":"Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22","volume":"85","author":"Tsai-Pflugfelder","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189727_bb0275","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41418-024-01257-x","article-title":"Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16\/TOP2A axis","volume":"31","author":"Zhang","year":"2024","journal-title":"Cell Death & Differentiation"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189727_bb0280","doi-asserted-by":"crossref","DOI":"10.1242\/bio.057729","article-title":"KDM5A and KDM5B histone-demethylases contribute to HU-induced replication stress response and tolerance","volume":"10","author":"Gaillard","year":"2021","journal-title":"Biology Open"},{"issue":"16","key":"10.1016\/j.bbcan.2026.189727_bb0285","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/onc.2014.155","article-title":"Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies","volume":"34","author":"Aye","year":"2015","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189727_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9050041","article-title":"Targeting the ATR-CHK1 axis in cancer therapy","volume":"9","author":"Rundle","year":"2017","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189727_bb0295","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/ijc.28226","article-title":"Roles of Chk1 in cell biology and cancer therapy","volume":"134","author":"Zhang","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189727_bb0300","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1006\/bcmd.1998.0167","article-title":"Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1alpha, in a phase I clinical trial in patients with relapsed\/refractory breast cancer","volume":"24","author":"Broxmeyer","year":"1998","journal-title":"Blood Cells Mol. Dis."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189727_bb0305","first-page":"2029","article-title":"Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations","volume":"48","author":"Choy","year":"1988","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189727_bb0310","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/sj.leu.2403006","article-title":"Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea","volume":"17","author":"Hehlmann","year":"2003","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189727_bb0315","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/0006-291X(87)91575-0","article-title":"Reversion of hydroxyurea resistance, decline in ribonucleotide reductase activity, and loss of M2 gene amplification","volume":"145","author":"McClarty","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189727_bb0320","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.7150\/thno.48101","article-title":"EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells","volume":"11","author":"Wen","year":"2021","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189727_bb0325","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41419-020-2426-z","article-title":"MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p\/AMPK\/PGC1\u03b1\/CEBPB axis to promote stemness and chemo-resistance of gastric cancer","volume":"11","author":"Wu","year":"2020","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189727_bb0330","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.406","article-title":"Silencing FLI or targeting CD13\/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells","volume":"8","author":"Azimi","year":"2017","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189727_bb0335","first-page":"1149","article-title":"Effect of ABT-888 on the apoptosis, motility and invasiveness of BRAFi-resistant melanoma cells","volume":"53","author":"Fratangelo","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"7674","key":"10.1016\/j.bbcan.2026.189727_bb0340","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nature24040","article-title":"PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas","volume":"550","author":"Lu","year":"2017","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189727_bb0345","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202215677","article-title":"The AhR-SRC axis as a therapeutic vulnerability in BRAFi-resistant melanoma","volume":"14","author":"Paris","year":"2022","journal-title":"EMBO Mol. Med."},{"issue":"24","key":"10.1016\/j.bbcan.2026.189727_bb0350","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1038\/sj.onc.1209379","article-title":"Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanoma","volume":"25","author":"Sensi","year":"2006","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189727_bb0355","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa1112302","article-title":"Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib","volume":"366","author":"Sosman","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189727_bb0360","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1158\/0008-5472.CAN-16-1755","article-title":"Myeloid cells that impair immunotherapy are restored in melanomas with acquired resistance to BRAF inhibitors","volume":"77","author":"Steinberg","year":"2017","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189727_bb0365","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1158\/1535-7163.MCT-18-0395","article-title":"KDM5B promotes drug resistance by regulating melanoma-propagating cell subpopulations","volume":"18","author":"Liu","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2026.189727_bb0370","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.719855","article-title":"LncRNA SNHG7 regulates mesenchymal stem cell through the Notch1\/Jagged1\/Hes-1 signaling pathway and influences Folfirinox resistance in pancreatic cancer","volume":"11","author":"Cheng","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189727_bb0375","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13578-021-00599-0","article-title":"Bone marrow mesenchymal stem cells promote prostate cancer cell stemness via cell-cell contact to activate the Jagged1\/Notch1 pathway","volume":"11","author":"Cheng","year":"2021","journal-title":"Cell Biosci."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189727_bb0380","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3324\/haematol.2019.221077","article-title":"Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance","volume":"105","author":"Colombo","year":"2020","journal-title":"Haematologica"},{"issue":"21","key":"10.1016\/j.bbcan.2026.189727_bb0385","doi-asserted-by":"crossref","first-page":"8543","DOI":"10.1074\/jbc.RA118.006983","article-title":"NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells","volume":"294","author":"Farah","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189727_bb0390","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1038\/s41598-022-07269-2","article-title":"Prognostic significance of intra-tumoral budding in high-grade serous ovarian carcinomas","volume":"12","author":"Hachisuga","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189727_bb0395","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3389\/fonc.2018.00575","article-title":"Notch signaling regulates mitochondrial metabolism and NF-\u03baB activity in triple-negative breast cancer cells via IKK\u03b1-dependent non-canonical pathways","volume":"8","author":"Hossain","year":"2018","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189727_bb0400","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41419-024-06512-0","article-title":"Ovarian tumor cell-derived JAGGED2 promotes omental metastasis through stimulating the Notch signaling pathway in the mesothelial cells","volume":"15","author":"Islam","year":"2024","journal-title":"Cell Death Dis."},{"issue":"18","key":"10.1016\/j.bbcan.2026.189727_bb0405","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1158\/1078-0432.CCR-17-1952","article-title":"Inhibition of HER2 increases JAGGED1-dependent breast cancer stem cells: role for membrane JAGGED1","volume":"24","author":"Shah","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189727_bb0410","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1111\/jcmm.14286","article-title":"Role of Jagged1\/STAT3 signalling in platinum-resistant ovarian cancer","volume":"23","author":"Yang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189727_bb0415","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.18632\/oncotarget.3241","article-title":"Acquisition of resistance to trastuzumab in gastric cancer cells is associated with activation of IL-6\/STAT3\/Jagged-1\/Notch positive feedback loop","volume":"6","author":"Yang","year":"2015","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189727_bb0420","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/jop.12406","article-title":"TGF\u03b21-Smad3-Jagged1-Notch1-slug signaling pathway takes part in tumorigenesis and progress of tongue squamous cell carcinoma","volume":"45","author":"Zhang","year":"2016","journal-title":"J. Oral Pathol. Med."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189727_bb0425","article-title":"JARID1B expression plays a critical role in chemoresistance and stem cell-like phenotype of neuroblastoma cells","volume":"10","author":"Ho","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189727_bb0430","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.7150\/ijbs.83774","article-title":"UPP1 enhances bladder cancer progression and gemcitabine resistance through AKT","volume":"20","author":"Du","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189727_bb0435","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1038\/s41467-018-07188-9","article-title":"The critical role of AMPK in driving Akt activation under stress, tumorigenesis and drug resistance","volume":"9","author":"Han","year":"2018","journal-title":"Nat. Commun."},{"issue":"51","key":"10.1016\/j.bbcan.2026.189727_bb0440","doi-asserted-by":"crossref","first-page":"30366","DOI":"10.1074\/jbc.M115.664169","article-title":"Endoplasmic reticulum (ER) stress induces Sirtuin 1 (SIRT1) expression via the PI3K-Akt-GSK3\u03b2 signaling pathway and promotes hepatocellular injury","volume":"290","author":"Koga","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189727_bb0445","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.7150\/ijbs.79126","article-title":"Mucin 4 confers gemcitabine resistance and an unfavorable prognosis in patients with cholangiocarcinoma via AKT activation","volume":"19","author":"Pan","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189727_bb0450","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2015.2","article-title":"DNA damage and the balance between survival and death in cancer biology","volume":"16","author":"Roos","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189727_bb0455","doi-asserted-by":"crossref","first-page":"12424","DOI":"10.1038\/s41598-023-32983-w","article-title":"TRIB1 confers therapeutic resistance in GBM cells by activating the ERK and Akt pathways","volume":"13","author":"Singh","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189727_bb0460","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fonc.2019.00422","article-title":"Aurora-a induces chemoresistance through activation of the AKT\/mTOR pathway in endometrial cancer","volume":"9","author":"Wu","year":"2019","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189727_bb0465","doi-asserted-by":"crossref","first-page":"382","DOI":"10.7150\/ijbs.99954","article-title":"Folic acid-modified Milk exosomes delivering c-kit siRNA overcome EGFR-TKIs resistance in lung cancer by suppressing mTOR signaling and stemness","volume":"21","author":"Xu","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"17","key":"10.1016\/j.bbcan.2026.189727_bb0470","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29173994","article-title":"Overcoming cancer drug resistance with nanoparticle strategies for key protein inhibition","volume":"29","author":"Yoo","year":"2024","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189727_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108596","article-title":"KDM5B predicts temozolomide-resistant subclones in glioblastoma","volume":"27","author":"Ullrich","year":"2024","journal-title":"iScience"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189727_bb0480","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2176\/nmc.ra.2018-0141","article-title":"Potential strategies overcoming the Temozolomide resistance for glioblastoma","volume":"58","author":"Jiapaer","year":"2018","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"issue":"Suppl. 4","key":"10.1016\/j.bbcan.2026.189727_bb0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/neuonc\/nou223","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbcan.2026.189727_bb0490","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/B978-0-12-802997-8.00023-2","article-title":"Glioblastoma","volume":"134","author":"Wirsching","year":"2016","journal-title":"Handb. Clin. Neurol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189727_bb0495","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3892\/etm.2020.8782","article-title":"TRIM31 enhances chemoresistance in glioblastoma through activation of the PI3K\/Akt signaling pathway","volume":"20","author":"Fan","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189727_bb0500","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1515\/med-2020-0157","article-title":"SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K\/AKT axis","volume":"15","author":"Gao","year":"2020","journal-title":"Open Med (Wars)"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189727_bb0505","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10555-016-9637-x","article-title":"PI3K\/AKT\/mTOR: role in breast cancer progression, drug resistance, and treatment","volume":"35","author":"Guerrero-Zotano","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbcan.2026.189727_bb0510","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1372330","article-title":"Regulation of ferroptosis by PI3K\/Akt signaling pathway: a promising therapeutic axis in cancer","volume":"12","author":"Su","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189727_bb0515","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/1759-7714.13328","article-title":"Targeting the PI3K\/Akt\/mTOR pathway in non-small cell lung cancer (NSCLC)","volume":"11","author":"Tan","year":"2020","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.bbcan.2026.189727_bb0520","doi-asserted-by":"crossref","DOI":"10.1177\/15330338241274369","article-title":"LncRNA NONHSAT227443.1 confers esophageal squamous cell carcinoma chemotherapy resistance by activating PI3K\/AKT signaling via targeting MRTFB","volume":"23","author":"Wang","year":"2024","journal-title":"Technol. Cancer Res. Treat."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189727_bb0525","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s12032-023-02137-z","article-title":"RNF149 confers cisplatin resistance in esophageal squamous cell carcinoma via destabilization of PHLPP2 and activating PI3K\/AKT signalling","volume":"40","author":"Zhu","year":"2023","journal-title":"Med. Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189727_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112162","article-title":"MiR-124 regulates liver cancer stem cells expansion and sorafenib resistance","volume":"394","author":"Feng","year":"2020","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189727_bb0535","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jhep.2019.08.035","article-title":"Targeting Jak\/stat pathway as a therapeutic strategy against SP\/CD44+ tumorigenic cells in Akt\/\u03b2-catenin-driven hepatocellular carcinoma","volume":"72","author":"Toh","year":"2020","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189727_bb0540","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/CAD.0000000000001329","article-title":"KDM5B regulates the PTEN\/PI3K\/Akt pathway to increase sorafenib-resistance in hepatocellular carcinoma","volume":"33","author":"Liu","year":"2022","journal-title":"Anticancer Drugs"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189727_bb0545","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41420-024-02020-4","article-title":"KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1\/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbcan.2026.189727_bb0550","doi-asserted-by":"crossref","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"9791","key":"10.1016\/j.bbcan.2026.189727_bb0555","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","article-title":"Pancreatic cancer","volume":"378","author":"Vincent","year":"2011","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189727_bb0560","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240766","article-title":"NFAT5 governs cellular plasticity-driven resistance to KRAS-targeted therapy in pancreatic cancer","volume":"221","author":"Deng","year":"2024","journal-title":"J. Exp. Med."},{"issue":"14","key":"10.1016\/j.bbcan.2026.189727_bb0565","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1038\/s41388-021-01726-4","article-title":"SMAD4 loss limits the vulnerability of pancreatic cancer cells to complex I inhibition via promotion of mitophagy","volume":"40","author":"Ezrova","year":"2021","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189727_bb0570","doi-asserted-by":"crossref","first-page":"742","DOI":"10.4161\/cc.8.5.7871","article-title":"TGFbeta prevents proteasomal degradation of the cyclin-dependent kinase inhibitor p27kip1 for cell cycle arrest","volume":"8","author":"Lecanda","year":"2009","journal-title":"Cell Cycle"},{"issue":"7832","key":"10.1016\/j.bbcan.2026.189727_bb0575","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41586-020-2850-3","article-title":"Cancer immunotherapy via targeted TGF-\u03b2 signalling blockade in T(H) cells","volume":"587","author":"Li","year":"2020","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189727_bb0580","first-page":"2527","article-title":"DPC4 gene in various tumor types","volume":"56","author":"Schutte","year":"1996","journal-title":"Cancer Res."},{"issue":"7540","key":"10.1016\/j.bbcan.2026.189727_bb0585","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","author":"Waddell","year":"2015","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189727_bb0590","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41419-024-07210-7","article-title":"SMAD4 limits PARP1 dependent DNA repair to render pancreatic cancer cells sensitive to radiotherapy","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189727_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189220","article-title":"New insight into the role of SMAD4 mutation\/deficiency in the prognosis and therapeutic resistance of pancreatic ductal adenocarcinomas","volume":"1879","author":"Yao","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189727_bb0600","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2014-15-2-r32","article-title":"KDM5B focuses H3K4 methylation near promoters and enhancers during embryonic stem cell self-renewal and differentiation","volume":"15","author":"Kidder","year":"2014","journal-title":"Genome Biol."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189727_bb0605","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/emboj.2011.91","article-title":"KDM5B regulates embryonic stem cell self-renewal and represses cryptic intragenic transcription","volume":"30","author":"Xie","year":"2011","journal-title":"EMBO J."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189727_bb0610","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nchembio.2085","article-title":"An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells","volume":"12","author":"Vinogradova","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189727_bb0615","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nchembio.2087","article-title":"Structural analysis of human KDM5B guides histone demethylase inhibitor development","volume":"12","author":"Johansson","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189727_bb0620","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.chembiol.2016.06.006","article-title":"Structural basis for KDM5A histone lysine demethylase inhibition by diverse compounds","volume":"23","author":"Horton","year":"2016","journal-title":"Cell Chem. Biol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189727_bb0625","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ccell.2018.10.014","article-title":"KDM5 histone demethylase activity links cellular transcriptomic heterogeneity to therapeutic resistance","volume":"34","author":"Hinohara","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189727_bb0630","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations","volume":"141","author":"Sharma","year":"2010","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189727_bb0635","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.cell.2017.01.010","article-title":"Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma","volume":"168","author":"Hugo","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189727_bb0640","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"6382","key":"10.1016\/j.bbcan.2026.189727_bb0645","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189727_bb0650","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189727_bb0655","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189727_bb0660","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189727_bb0665","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.4049\/jimmunol.1401869","article-title":"STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells","volume":"193","author":"Klarquist","year":"2014","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189727_bb0670","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2006134","article-title":"KDM5 histone demethylases repress immune response via suppression of STING","volume":"16","author":"Wu","year":"2018","journal-title":"PLoS Biol."},{"issue":"7882","key":"10.1016\/j.bbcan.2026.189727_bb0675","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-021-03994-2","article-title":"KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements","volume":"598","author":"Zhang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189727_bb0680","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-immunol-032414-112240","article-title":"Innate immune pattern recognition: a cell biological perspective","volume":"33","author":"Brubaker","year":"2015","journal-title":"Annu. Rev. Immunol."},{"issue":"7213","key":"10.1016\/j.bbcan.2026.189727_bb0685","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling","volume":"455","author":"Ishikawa","year":"2008","journal-title":"Nature"},{"issue":"6121","key":"10.1016\/j.bbcan.2026.189727_bb0690","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"issue":"7548","key":"10.1016\/j.bbcan.2026.189727_bb0695","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nature14156","article-title":"Mitochondrial DNA stress primes the antiviral innate immune response","volume":"520","author":"West","year":"2015","journal-title":"Nature"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X2600199X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X2600199X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:07:59Z","timestamp":1791576479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X2600199X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":139,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0304419X2600199X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189727","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lysine specific demethylase 5B promises to be a new focus of cancer drug-resistance: combination therapy","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189727"}}